Navigation Links
Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production
Date:8/18/2009

New Molecular Toolkit Optimizes Algae Performance and Productivity

ALAMEDA, Calif., Aug. 18 /PRNewswire/ -- Today, Aurora Biofuels announces a technological milestone in the company's path to becoming the premier producer of low-cost advanced biofuels. Through a series of biotechnology achievements, Aurora has succeeded in optimizing its base algae strains to more than double CO2 consumption and fuel production, and has proven these results in an outdoor open system over the last several months.

Using tools developed in the fields of molecular biology and biochemistry, Aurora Biofuels scientists have developed a proprietary process which allows for the superior selection and breeding of non-transgenic algae. With this novel technique, the company has optimized its base algae strains with an increased ability to process sunlight and carbon dioxide into algal oil. As a result, these algae strains can produce more than twice the amount of oil. Optimized algae have been producing oil in Aurora Biofuels' outdoor pilot ponds for several months, providing strong evidence that these strains will remain robust at the industrial scale and remove more carbon emissions than previously thought possible.

"This is a major breakthrough showing that one can take algae with improved productivity from the research lab to the field. What Aurora scientists have achieved is an impressive milestone on the path to large-scale commercial algae production," said Kris Niyogi, a member of the company's scientific advisory board and professor of algal biology at the University of California, Berkeley.

"This is a game-changing development for our company, as our newly optimized algae, novel harvesting and extraction processes create a world-class, low-cost biofuel platform," said Bob Walsh, CEO of Aurora Biofuels. "There's a lot of noise about algae lately, but it's all talk until you prove it outdoors," he said. "This advancement, now proven for months in our pilot ponds, shows that we've met that rigid criteria and are now ready for the demonstration scale."

About Aurora Biofuels:

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel generation, using robust and highly-productive custom algae strains. The Aurora Biofuels process is carbon-mitigating and non-competitive with agricultural resources, and capable of industrial yields with a minimal land requirement. Aurora Biofuels investors include: Oak Investment Partners, Noventi Ventures and Gabriel Venture Partners.


'/>"/>
SOURCE Aurora Biofuels
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
2. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
5. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
6. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
7. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
8. NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board
9. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
10. Performance Plants Establishes U.S. Biofuels Facility
11. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... ... can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical ... and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented ...
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company ... National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month ... technology and is expected to deliver therapeutic levels of olanzapine for a period of ...
(Date:2/24/2017)... San Diego, Calif. (PRWEB) , ... February 24, 2017 , ... ... African food and wine scene. Making stops in several cities, she gained a ... Her culinary adventure began in Stellenbosch, a town in South Africa’s Western Cape province. ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
Breaking Biology News(10 mins):